N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide

C101H125BrF10N16O9 — CID 158414466

IUPACN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide
SMILESCC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(C)CC(=O)Nc1nc2c(F)cc(C(O)(CF)CF)cc2n1C1CCC1.CC(O)(CC(=O)Nc1nc2cc(F)c(C#N)cc2n1C1(C)CCC1)c1ccccc1F.CCC(C)(CF)CC(=O)Nc1nc2c(F)cc(C(C)(C)O)cc2n1C1(C)CCC1.COc1cccc2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c12
InChIInChI=1S/C23H22F2N4O2.C22H31F2N3O2.C20H26F3N3O2.C18H21BrF3N3O.C18H25N3O2/c1-22(8-5-9-22)29-19-10-14(13-26)17(25)11-18(19)27-21(29)28-20(30)12-23(2,31)15-6-3-4-7-16(15)24;1-6-21(4,13-23)12-17(28)25-19-26-18-15(24)10-14(20(2,3)29)11-16(18)27(19)22(5)8-7-9-22;1-19(2,3)9-16(27)24-18-25-17-14(23)7-12(20(28,10-21)11-22)8-15(17)26(18)13-5-4-6-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)11-15(22)20-17-19-13-9-6-10-14(23-4)16(13)21(17)12-7-5-8-12/h3-4,6-7,10-11,31H,5,8-9,12H2,1-2H3,(H,27,28,30);10-11,29H,6-9,12-13H2,1-5H3,(H,25,26,28);7-8,13,28H,4-6,9-11H2,1-3H3,(H,24,25,27);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);6,9-10,12H,5,7-8,11H2,1-4H3,(H,19,20,22)
InChIKeyGZSFAOXAGOTEIR-UHFFFAOYSA-N
MW1977.10 g/mol
LogP23.80
Rot. Bonds25

About N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide

N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide (PubChem CID 158414466) has the molecular formula C101H125BrF10N16O9 and a molecular weight of 1977.10 g/mol. Its IUPAC name is N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide.

Molecular Properties

Compound NameN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide
PubChem CID158414466
Molecular FormulaC101H125BrF10N16O9
Molecular Weight1977.10 g/mol
Exact Mass1974.88
IUPAC NameN-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide
SMILESCC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(C)CC(=O)Nc1nc2c(F)cc(C(O)(CF)CF)cc2n1C1CCC1.CC(O)(CC(=O)Nc1nc2cc(F)c(C#N)cc2n1C1(C)CCC1)c1ccccc1F.CCC(C)(CF)CC(=O)Nc1nc2c(F)cc(C(C)(C)O)cc2n1C1(C)CCC1.COc1cccc2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c12
InChIInChI=1S/C23H22F2N4O2.C22H31F2N3O2.C20H26F3N3O2.C18H21BrF3N3O.C18H25N3O2/c1-22(8-5-9-22)29-19-10-14(13-26)17(25)11-18(19)27-21(29)28-20(30)12-23(2,31)15-6-3-4-7-16(15)24;1-6-21(4,13-23)12-17(28)25-19-26-18-15(24)10-14(20(2,3)29)11-16(18)27(19)22(5)8-7-9-22;1-19(2,3)9-16(27)24-18-25-17-14(23)7-12(20(28,10-21)11-22)8-15(17)26(18)13-5-4-6-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)11-15(22)20-17-19-13-9-6-10-14(23-4)16(13)21(17)12-7-5-8-12/h3-4,6-7,10-11,31H,5,8-9,12H2,1-2H3,(H,27,28,30);10-11,29H,6-9,12-13H2,1-5H3,(H,25,26,28);7-8,13,28H,4-6,9-11H2,1-3H3,(H,24,25,27);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);6,9-10,12H,5,7-8,11H2,1-4H3,(H,19,20,22)
InChIKeyGZSFAOXAGOTEIR-UHFFFAOYSA-N
XLogP23.80
TPSA328.31 Ų
H-Bond Donors8
H-Bond Acceptors20
Rotatable Bonds25
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001977.10
LogP ≤ 523.80
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1020

Analyze N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide?
The IUPAC name of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide (CID 158414466) is N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide.
What is the SMILES notation for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide?
The canonical SMILES for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide is CC(C)(C)CC(=O)Nc1nc2c(C(F)(F)F)cc(Br)cc2n1C1CCC1.CC(C)(C)CC(=O)Nc1nc2c(F)cc(C(O)(CF)CF)cc2n1C1CCC1.CC(O)(CC(=O)Nc1nc2cc(F)c(C#N)cc2n1C1(C)CCC1)c1ccccc1F.CCC(C)(CF)CC(=O)Nc1nc2c(F)cc(C(C)(C)O)cc2n1C1(C)CCC1.COc1cccc2nc(NC(=O)CC(C)(C)C)n(C3CCC3)c12.
What is the InChIKey of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide?
The InChIKey is GZSFAOXAGOTEIR-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H22F2N4O2.C22H31F2N3O2.C20H26F3N3O2.C18H21BrF3N3O.C18H25N3O2/c1-22(8-5-9-22)29-19-10-14(13-26)17(25)11-18(19)27-21(29)28-20(30)12-23(2,31)15-6-3-4-7-16(15)24;1-6-21(4,13-23)12-17(28)25-19-26-18-15(24)10-14(20(2,3)29)11-16(18)27(19)22(5)8-7-9-22;1-19(2,3)9-16(27)24-18-25-17-14(23)7-12(20(28,10-21)11-22)8-15(17)26(18)13-5-4-6-13;1-17(2,3)9-14(26)23-16-24-15-12(18(20,21)22)7-10(19)8-13(15)25(16)11-5-4-6-11;1-18(2,3)11-15(22)20-17-19-13-9-6-10-14(23-4)16(13)21(17)12-7-5-8-12/h3-4,6-7,10-11,31H,5,8-9,12H2,1-2H3,(H,27,28,30);10-11,29H,6-9,12-13H2,1-5H3,(H,25,26,28);7-8,13,28H,4-6,9-11H2,1-3H3,(H,24,25,27);7-8,11H,4-6,9H2,1-3H3,(H,23,24,26);6,9-10,12H,5,7-8,11H2,1-4H3,(H,19,20,22).
What are the key properties of N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide?
N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide has a molecular weight of 1977.10 g/mol, XLogP of 23.80, 25 rotatable bonds, 8 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-bromo-1-cyclobutyl-4-(trifluoromethyl)benzimidazol-2-yl]-3,3-dimethylbutanamide;N-[6-cyano-5-fluoro-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(2-fluorophenyl)-3-hydroxybutanamide;N-[1-cyclobutyl-6-(1,3-difluoro-2-hydroxypropan-2-yl)-4-fluorobenzimidazol-2-yl]-3,3-dimethylbutanamide;N-(1-cyclobutyl-7-methoxybenzimidazol-2-yl)-3,3-dimethylbutanamide;N-[4-fluoro-6-(2-hydroxypropan-2-yl)-1-(1-methylcyclobutyl)benzimidazol-2-yl]-3-(fluoromethyl)-3-methylpentanamide is sourced from PubChem (CID 158414466), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).